INFU 📈 InfuSystems Holdings - Overview
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45685K1025
INFU: Infusion Pumps, Medical Equipment, Supplies, Services
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. Web URL: https://www.infusystem.com
Additional Sources for INFU Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
INFU Stock Overview
Market Cap in USD | 188m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2007-12-27 |
INFU Stock Ratings
Growth 5y | -27.9% |
Fundamental | 8.32% |
Dividend | - |
Rel. Strength Industry | -516 |
Analysts | 5/5 |
Fair Price Momentum | 8.00 USD |
Fair Price DCF | 7.23 USD |
INFU Dividends
No Dividends PaidINFU Growth Ratios
Growth Correlation 3m | 71.2% |
Growth Correlation 12m | -53.6% |
Growth Correlation 5y | -62.2% |
CAGR 5y | -0.45% |
CAGR/Mean DD 5y | -0.01 |
Sharpe Ratio 12m | -0.30 |
Alpha | -56.50 |
Beta | 1.38 |
Volatility | 83.38% |
Current Volume | 127.7k |
Average Volume 20d | 72.2k |
What is the price of INFU stocks?
As of December 22, 2024, the stock is trading at USD 8.31 with a total of 127,699 shares traded.
Over the past week, the price has changed by -6.73%, over one month by -7.87%, over three months by +28.64% and over the past year by -21.38%.
As of December 22, 2024, the stock is trading at USD 8.31 with a total of 127,699 shares traded.
Over the past week, the price has changed by -6.73%, over one month by -7.87%, over three months by +28.64% and over the past year by -21.38%.
Is InfuSystems Holdings a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, InfuSystems Holdings is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.32 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INFU as of December 2024 is 8.00. This means that INFU is currently overvalued and has a potential downside of -3.73%.
Neither. Based on ValueRay Fundamental Analyses, InfuSystems Holdings is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.32 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INFU as of December 2024 is 8.00. This means that INFU is currently overvalued and has a potential downside of -3.73%.
Is INFU a buy, sell or hold?
InfuSystems Holdings has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy INFU.
InfuSystems Holdings has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy INFU.
- Strong Buy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for INFU stock price target?
According to ValueRays Forecast Model, INFU InfuSystems Holdings will be worth about 8.9 in December 2025. The stock is currently trading at 8.31. This means that the stock has a potential upside of +7.22%.
According to ValueRays Forecast Model, INFU InfuSystems Holdings will be worth about 8.9 in December 2025. The stock is currently trading at 8.31. This means that the stock has a potential upside of +7.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14.1 | 70% |
Analysts Target Price | 15.8 | 90.5% |
ValueRay Target Price | 8.9 | 7.2% |